Xiaoang Yang
- Topics
- Hepatitis C virus research (4 papers)SARS-CoV-2 and COVID-19 Research (3 papers)Hepatitis B Virus Studies (3 papers)
- Partner nations
- ChinaIranUnited States
In The Last Decade
Xiaoang Yang
15 papers receiving 390 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 206
- Immunology 198
- Epidemiology 70
- Cancer Research 69
- Infectious Diseases 59
Countries citing papers authored by Xiaoang Yang
This map shows the geographic impact of Xiaoang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoang Yang more than expected).
Fields of papers citing papers by Xiaoang Yang
This network shows the impact of papers produced by Xiaoang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoang Yang. The network helps show where Xiaoang Yang may publish in the future.
Co-authorship network of co-authors of Xiaoang Yang
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoang Yang. A scholar is included among the top collaborators of Xiaoang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoang Yang. Xiaoang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 8 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 15 | |
| 7 | 10 | |
| 8 | 13 | |
| 9 | 12 | |
| 10 | 49 | |
| 11 | 21 | |
| 12 | 235 | |
| 13 | 19 | |
| 14 | [Expression and purification of recombinant N-terminal protein of SARS S1 subunit expressed in E. Coli]. | 1 |
| 15 | [The cloning, expression, purification and identification of SARS virus S2 gene and study on its immunological characteristics]. | 1 |
About Xiaoang Yang
Xiaoang Yang is a scholar working on Hepatology, Infectious Diseases and Cancer Research, having authored 15 papers that have together received 396 indexed citations. Recurring topics across this work include Hepatitis C virus research (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Hepatitis B Virus Studies (3 papers). The work is most often cited by research in Immunology (198 citations), Cancer Research (69 citations) and Infectious Diseases (59 citations). Xiaoang Yang has collaborated with scholars based in China, Iran and United States. Frequent co-authors include Xiaojun Xia, Rongfu Wang, Helen Y. Wang, Qinfu Wang, Liang Zhu, Jun Ki Hong, Jun Cui, Satoko Matsueda, Zhou Songyang and Zhijian J. Chen. Their work appears in journals such as Immunity, European Journal of Pharmacology and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.